Wendy B. Young, Director at Rapport Therapeutics, Inc. (RAPP), bought 12,000 shares at $10.21 ($123K) on 2025-03-12, disclosed to the SEC on 2025-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.21 | 6,000 | $61K | 50.0% |
| 2 | $10.21 | 6,000 | $61K | 50.0% |
| Total | $10.21 avg | 12,000 | $123K | 100% |